Anjan Dhar

5.7k total citations · 1 hit paper
99 papers, 1.6k citations indexed

About

Anjan Dhar is a scholar working on Surgery, Epidemiology and Gastroenterology. According to data from OpenAlex, Anjan Dhar has authored 99 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 22 papers in Epidemiology and 17 papers in Gastroenterology. Recurrent topics in Anjan Dhar's work include Gastric Cancer Management and Outcomes (12 papers), Inflammatory Bowel Disease (12 papers) and Esophageal and GI Pathology (10 papers). Anjan Dhar is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Inflammatory Bowel Disease (12 papers) and Esophageal and GI Pathology (10 papers). Anjan Dhar collaborates with scholars based in United Kingdom, India and United States. Anjan Dhar's co-authors include Amitabha Ray, Stephen Allen, A Foden, Caroline Bradley, Hayley Hutchings, Mark Thursz, Mike B. Gravenor, Dietrich Mack, Kathie Wareham and Duolao Wang and has published in prestigious journals such as The Lancet, Gastroenterology and Gut.

In The Last Decade

Anjan Dhar

87 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults

2022 106 citations Anjan Dhar, Hasan Haboubi et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anjan Dhar United Kingdom	20	566	365	256	250	248	99	1.6k
Yoo Jin Lee South Korea	21	513 0.9×	288 0.8×	378 1.5×	129 0.5×	287 1.2×	141	1.6k
Jae Sung Ko South Korea	20	669 1.2×	453 1.2×	256 1.0×	130 0.5×	218 0.9×	167	1.7k
Huadong Zhu China	21	327 0.6×	394 1.1×	218 0.9×	234 0.9×	190 0.8×	153	1.5k
Giuseppe Fabio Parisi Italy	24	438 0.8×	488 1.3×	574 2.2×	136 0.5×	133 0.5×	134	1.9k
V. Loustaud‐Ratti France	28	450 0.8×	1.2k 3.3×	346 1.4×	214 0.9×	165 0.7×	141	2.9k
Nurdan Tözün Türkiye	25	544 1.0×	753 2.1×	188 0.7×	98 0.4×	183 0.7×	106	1.8k
Muhammad Aziz United States	22	575 1.0×	288 0.8×	503 2.0×	501 2.0×	147 0.6×	164	1.9k
Emanuele Sinagra Italy	20	519 0.9×	259 0.7×	350 1.4×	66 0.3×	292 1.2×	116	1.5k
Frank I. Scott United States	24	547 1.0×	523 1.4×	207 0.8×	94 0.4×	252 1.0×	118	1.8k
Soo‐Kyung Park South Korea	20	315 0.6×	144 0.4×	422 1.6×	252 1.0×	561 2.3×	87	1.6k

Countries citing papers authored by Anjan Dhar

Since Specialization

Citations

This map shows the geographic impact of Anjan Dhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjan Dhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjan Dhar more than expected).

Fields of papers citing papers by Anjan Dhar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anjan Dhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjan Dhar. The network helps show where Anjan Dhar may publish in the future.

Co-authorship network of co-authors of Anjan Dhar

This figure shows the co-authorship network connecting the top 25 collaborators of Anjan Dhar. A scholar is included among the top collaborators of Anjan Dhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anjan Dhar. Anjan Dhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dhar, Anjan, et al.. (2025). Cytokine Release Syndrome and Arrhythmia After CAR-T Cell Therapy in a Pediatric Heart Transplant Recipient with Refractory PTLD. The Journal of Heart and Lung Transplantation. 44(4). S251–S251.

Iqbal, Tariq, et al.. (2024). Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England. Journal of Medical Economics. 27(1). 392–403. 5 indexed citations

Dhar, Anjan, et al.. (2024). P241 Diagnostic and surveillance upper gastrointestinal endoscopy practice in UK hospitals: results of a BSG EQIP survey. Poster presentations. A192–A193. 1 indexed citations

Burr, Nicholas, Chris Healey, Richard Tighe, et al.. (2024). O53 The causes of post endoscopy upper gastrointestinal cancer: pilot results from the national root cause analysis project. Oral Presentations. A32.2–A33. 2 indexed citations

Dhar, Anjan, Hasan Haboubi, Marcus Auth, & Stephen Attwood. (2022). Eosinophilic oesophagitis: improving diagnosis and therapy – reducing the burden of repeated endoscopy. Frontline Gastroenterology. 13(e1). e51–e56. 2 indexed citations

Dhar, Anjan, Hasan Haboubi, Stephen Attwood, et al.. (2022). British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut. 71(8). 1459–1487. 106 indexed citations breakdown →

Chambers, Thomas M., et al.. (2022). P250 Barium vs endoscopy for diagnosis of UGI cancer, stratified by Edinburgh dysphagia score during COVID-19. Poster presentations. A162.2–A163.

Dhar, Anjan, et al.. (2020). Side effects of drug treatments for gastro-oesophageal reflux disease: current controversies. Frontline Gastroenterology. 13(1). 45–49. 5 indexed citations

Menon, Shyam, et al.. (2016). Factors Associated with Upper Gastrointestinal Cancer Occurrence After Endoscopy that Did Not Diagnose Cancer. Digestive Diseases and Sciences. 61(9). 2674–2684. 19 indexed citations

10.

Dhar, Anjan. (2014). Biodegradable stent or balloon dilatation for benign oesophageal stricture: Pilot randomised controlled trial. World Journal of Gastroenterology. 20(48). 18199–18199. 19 indexed citations

11.

Dhar, Anjan, et al.. (2013). PTH-094 Faecal Calprotectin Testing in Primary and Secondary Care – are the Current Manufacturer’S Cut-Off Levels Clinically Useful?. Gut. 62(Suppl 1). A249.2–A249. 6 indexed citations

12.

Allen, Stephen, Kathie Wareham, Duolao Wang, et al.. (2013). Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. 382(9900). 1249–1257. 250 indexed citations

13.

Allen, Susan, K. Wareham, Caroline Bradley, et al.. (2013). PWE-008 Placide: Probiotics in the Prevention of Antibiotic Associated Diarrhoea (AAD) and Clostridium Difficile Associated Diarrhoea (CDD) in Elderly Patients Admitted to Hospital – Results of a Large Multi-Centre RCT in the UK. Gut. 62(Suppl 1). A133.2–A133. 2 indexed citations

14.

Petts, Gemma, Anjan Dhar, Hiromi Kudo, et al.. (2012). OC-065 Targeted inhibition of tissue factor and thrombin on CD31 expressing cells suppresses hepatic fibrosis in CCl4 treated mice. Gut. 61(Suppl 2). A28.2–A28. 1 indexed citations

15.

Ross, Janine, et al.. (2012). PWE-098 Clostridium difficile diarrhoea—the changing hospital epidemiology and clinical outcomes from a high prevalence area in North East England. Gut. 61(Suppl 2). A336.3–A337. 1 indexed citations

16.

Dhar, Anjan, et al.. (2012). PTU-153 Can a 10 year fracture risk score (FRAX) be used to avoid dual energy x-ray absorptiometry (DEXA) scans in patients with coeliac disease?. Gut. 61(Suppl 2). A248.1–A248. 1 indexed citations

17.

Dhar, Anjan, et al.. (2011). P104 Coagulation proteins in liver fibrosis: a role for tissue factor and fibrin/fibrinogen. Gut. 60(Suppl 2). A48.2–A48. 2 indexed citations

18.

Walsh, Kevin, et al.. (2010). PTU-053 Is procollagen III aminopeptide a good predictor of liver fibrosis in patients with psoriasis on methotrexate therapy?. A70.1–A70.

19.

Kang, Jin-Yong, Anjan Dhar, Richard Pollok, et al.. (2004). Diverticular disease of the colon: ethnic differences in frequency. Alimentary Pharmacology & Therapeutics. 19(7). 765–769. 36 indexed citations

20.

Dhar, Anjan, Mahesh K. Goenka, Rakesh Kochhar, et al.. (1996). Pancrease divisum: five years' experience in a teaching hospital.. PubMed. 15(1). 7–9. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact